The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Orgenesis Inc. - Cell Therapy and Regenerative Medicine Company Focused on Developing Cure for Type 1 Diabetes

SNNLive spoke with Vered Caplan, CEO of Orgenesis Inc. (OTCQB: ORGS) at the B. Riley & Co. Investor Conference 2015 in Hollywood, CA.

Share With

Monday, June 15, 2015


© 2019 Stock News Now